PRDM16 protects retinal ganglion cells from ischemia-reperfusion Injury by regulating the RPL5/p53 axis.
Saved in:
| Title: | PRDM16 protects retinal ganglion cells from ischemia-reperfusion Injury by regulating the RPL5/p53 axis. |
|---|---|
| Authors: | Feng Y; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., Li Z; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., Lu J; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., Peng X; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., He Z; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., Jia A; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., Bao Y; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China., Zheng Q; Department of Emergency, Sichuan, China.; Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China., Xu X; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China., Ma Y; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China., Zou C; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China., Li H; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China. lihuiling@csu.edu.cn.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China. lihuiling@csu.edu.cn., Zhang D; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China. dongshanzhang@csu.edu.cn.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. dongshanzhang@csu.edu.cn.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China. dongshanzhang@csu.edu.cn. |
| Source: | Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2026 Mar 30; Vol. 83 (1). Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41910727 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PRDM16 protects retinal ganglion cells from ischemia-reperfusion Injury by regulating the RPL5/p53 axis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Feng+Y%22">Feng Y</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Peng+X%22">Peng X</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22He+Z%22">He Z</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Jia+A%22">Jia A</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Bao+Y%22">Bao Y</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Zheng+Q%22">Zheng Q</searchLink>; Department of Emergency, Sichuan, China.; Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink>; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Ma+Y%22">Ma Y</searchLink>; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Zou+C%22">Zou C</searchLink>; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, China. lihuiling@csu.edu.cn.; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, 410011, Hunan, China. lihuiling@csu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Zhang+D%22">Zhang D</searchLink>; Department of Critical Care Medicine, The Second Xiangya Hospital, Central South University, Renming Middle Road, Changsha, Hunan, 410011, People's Republic of China. dongshanzhang@csu.edu.cn.; Emergency Medicine and Difficult Diseases Institute, Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. dongshanzhang@csu.edu.cn.; Furong Laboratory, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China. dongshanzhang@csu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229705402%22">Cellular and molecular life sciences : CMLS</searchLink> [Cell Mol Life Sci] 2026 Mar 30; Vol. 83 (1). <i>Date of Electronic Publication: </i>2026 Mar 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9705402 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1420-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221420682X%22">1420682X </searchLink><i>NLM ISO Abbreviation: </i>Cell Mol Life Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41910727 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00018-026-06187-0 Languages: – Code: eng Text: English Titles: – TitleFull: PRDM16 protects retinal ganglion cells from ischemia-reperfusion Injury by regulating the RPL5/p53 axis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Feng Y – PersonEntity: Name: NameFull: Li Z – PersonEntity: Name: NameFull: Lu J – PersonEntity: Name: NameFull: Peng X – PersonEntity: Name: NameFull: He Z – PersonEntity: Name: NameFull: Jia A – PersonEntity: Name: NameFull: Bao Y – PersonEntity: Name: NameFull: Zheng Q – PersonEntity: Name: NameFull: Xu X – PersonEntity: Name: NameFull: Ma Y – PersonEntity: Name: NameFull: Zou C – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Zhang D IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 03 Text: 2026 Mar 30 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1420-9071 Numbering: – Type: volume Value: 83 – Type: issue Value: 1 Titles: – TitleFull: Cellular and molecular life sciences : CMLS Type: main |
| ResultId | 1 |